Company Profile
Jinling Pharmaceutical manufactures and sells pharmaceuticals and medical devices in China and globally. It offers Mailuoning injection and oral solution for the treatment of thromboangiitis and arteriosclerosis obliterans, as well as cerebral and venous thrombosis.
Its portfolio also includes Sulifei, a ferrous succinate tablet for the prevention and treatment of iron deficiency anemia, Lentinan injection, an adjuvant therapy for the treatment of malignant tumors, and absorbable gelatin sponges for the treatment of wound bleeding and trauma hemostasis Traditional Chinese medicines, chemical medicines, active pharmaceutical ingredients, and pharmaceutical intermediates.
Additionally, it engages in elderly care services, rehabilitation therapy, psychological counseling, and end-of-life care. Its portfolio also includes hospital management, technical services, and healthcare investment activities. Incorporated in 1998, the company is headquartered in Nanjing, China.